TomBot offering is now closed and is no longer accepting investments.

Robotic emotional support animals

INVEST IN TOMBOT TODAY!

Tombot makes robotic animals for seniors with dementia. Our aim is to become the first affordable, FDA-regulated robotic animal, providing mental and physical health benefits for people who cannot safely or practically care for live animals.
... Show more
This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
TomBot

REASONS TO INVEST

Reasons Icon

Named one of TIME Magazine’s 2020 Best Inventions, Tombot’s realistic robotic animals were designed to help 50M+ seniors with dementia and mild cognitive impairment worldwide. This number is projected to reach 152M+ by 2050.

Reasons Icon

Tombot conducted three rounds of consumer studies involving 100’s of dementia patients during product design, demonstrating their strong preference for realism.

Reasons Icon

$4M+ in commitments from institutional and accredited angel investors, with 8,500+ pre-order and waitlist customers.

The Overview


A companion to provide comfort to those coping with dementia

The inspiration for Tombot emerged in 2011, when CEO and Co-Founder Tom Stevens faced an incredibly tough decision: Tom’s mother, Nancy, had been diagnosed with Alzheimer’s and was no longer able to safely care for her beloved dog and best friend, Golden Bear. When Tom took Golden Bear away, Nancy’s severe loneliness, depression, and violent anger all worsened. Tom looked around for live animal companion substitutes but couldn’t find anything Nancy liked.  Determined to find a solution, Tom embarked on a multi-year education and research journey. Six years later, Tombot was born.  


We’ve already sold out our first litter of Puppies in pre-order, and our waitlist recently crossed the 8,500 mark.  Our customers, hailing from 76 countries around the world, include B2B organizations such as assisted living and skilled nursing facilities, behavioral health institutions, home health agencies, and K-12 schools. In addition to seniors with dementia, we have received orders from seniors living on their own, parents of children with Autism, and adults with loneliness, chronic pain, major depressive disorder, anxiety, bipolar disorder, and PTSD.  

THE PROBLEM


Seniors with dementia and chronic pain need better alternatives to toxic medications


Tombot’s go-to-market customers are seniors with dementia.  97% of seniors with dementia suffer from debilitating symptoms including loneliness, frustration, delirium, hallucinations, and violent anger. Additionally, over 80% of seniors in nursing homes experience chronic pain. Doctors frequently prescribe these patients psychotropic and opioid medications. In addition to turning seniors into zombies, psychotropics can kill, and opioids increase fall risk. 


Source 1, Source 2Source 3


These severe symptoms are not just experienced by seniors and nursing home residents.  Loneliness and depression occur in long-term hospital patients, as well as the adolescent and adult populations at large—all exacerbated by Covid-19.

Few non-pharmacological alternatives to psychotropics exist, leaving doctors and family members of dementia patients desperate for solutions. 





THE SOLUTION


A thoughtfully designed robotic animal companion

Peer-reviewed studies have shown that robotic animal companions positively contribute to the ability to cope with stress, anxiety, loneliness, depression, and pain, thus improving overall well-being. Research shows that robotic animals significantly outperform traditional objects, such as dolls or stuffed animals, with the added benefit of reducing pain and the need for pain medications1.

Current competitors in the robotic animal space fall into one of two camps: simplistic children’s toys, or prohibitively expensive robots (Paro, the wide-eyed seal pup, and Sony’s Aibo dog cost $6,400 and $2,900, respectively). For a small fraction of the price, Tombot will incorporate additional features promoting emotional attachment.

Barking up exactly the right tree

Jennie is designed to stimulate emotional attachment and help individuals, families, and communities cope with a spectrum of health adversities at a price most people can afford. She is responsive to touch, voice, movement, and light, and is integrated with a smartphone app that enables customization and software updates to expand and improve her capabilities over time.

Jennie’s body is covered in sensors, allowing her to feel how and where she is being touched or moved, and to hear sounds and voice commands. In order to emulate real dogs, she has been carefully programmed with a rich set of behaviors and sounds.



Her patented realistic appearance and texture were designed with the artistic services of Jim Henson’s Creature Shop, known for its unmatched expertise and artistic creativity. Tombot has filed additional patent applications in the USPTO and the international PCT.

Jennie sells for $449. We intend for all future models to also carry a monthly subscription charge. Our two-pronged business model allows us to sell directly to consumers, as well as B2B2C through assisted living and skilled nursing facilities.


THE MARKET


A multi-billion-dollar market that we believe will only keep growing



There are currently over 50 million seniors with dementia and mild cognitive impairment worldwide. This number is projected to grow to over 152 million by 2030. But Tombot’s reach doesn’t end there. Robotic pets are on the rise

why invest 


Providing companionship to those who need it most

Jennie has been greeted with curiosity and enthusiasm by customers from 76 countries around the world. Our goal is to support and uplift individuals coping with adversities, as well as their families and communities. Many people across the globe cannot safely or practically care for a live animal, but still yearn for the company of a pet. Tombot offers a safe and novel solution to this problem. 


We’re ready to become the world’s largest social robotics company.


Labrador puppies are just the start—there’s a world of possibilities. Our product roadmap of increasingly sophisticated technology and designs will serve an expanding customer base.


We invite you to join us in transforming daily lives and providing companionship to individuals everywhere.


1. Petersen et al., The Utilization of Robotic Pets in Dementia Care; Journal of Alzheimer’s Disease, Vol. 55 (2017)




Code View

ABOUT

HEADQUARTERS
19197 Golden Valley Road, #638
Santa Clarita, CA 91387
VALUATION
$14.49M

Tombot makes robotic animals for seniors with dementia. Our aim is to become the first affordable, FDA-regulated robotic animal, providing mental and physical health benefits for people who cannot safely or practically care for live animals.

TEAM

Henry P. Schorz

Henry P. Schorz

Chief Technical Officer

Hank has been a Chief-level executive for more than 40 years. As an engineering and operations expert, Hank has built multiple companies into industry leaders. Hank’s technical curiosity and systems mentality give him the unique ability to fundamentally understand all of the elements of complex systems and processes. These skills have been applied to consumer electronics design and manufacturing, custom software development, computer systems integration, and very large data processing and management, and now robotics.

Hank has also spent many years as a hobbyist roboticist and remote-control airplane builder and competitor. These experiences, combined with his career in engineering and systems design gave Hank the insight on how to technically execute the Tombot robots. Inventing the perception, control and behavior systems for Tombot’s robots, Hank’s ingenuity has led to the filing of a comprehensive family of patents.

Jesse M. Schorz

Jesse M. Schorz

Chief Operating Officer

Jesse has spent 20 years in management and leadership positions. Jesse built and managed high-performing internal engineering and operations teams - the largest operating divisions at ACT. Jesse also oversaw very large contract teams and 3rd party suppliers. These experiences have led Jesse to develop best-practices operations systems.

In addition to his technical skills and business acumen, Jesse is a “get stuff done” guy. Creating and adhering to operating budgets and timelines are core strengths. Jesse’s skills begin with the innate ability to accurately forecast budgets and timelines. Accurate projections are critical for the financial management of Tombot, and for setting appropriate customer and investor expectations.

In addition to setting-up Tombot’s IT and operations systems, Jesse constructed and produced all of the realistic behaviors in our prototypes. Jesse leads all aspects of the identification, selection and oversight of Tombot’s supply chain, including the performance testing of key components.

Thomas Edward Stevens

Thomas Edward Stevens

Chairman - Board of Directors

Tom has been in the high tech industry since 1985 - the early days of the PC revolution. The extraordinary demand for PCs at the time far outstripped the supply of workers, creating unusual opportunities for anyone involved. At Novell, Tom was repeatedly promoted and given responsibilities that would only have been attainable after decades of service in more mature industries. Tom was fortunate to receive the necessary training, support and mentorship from senior leadership to take on these heady challenges.

These early experiences provided Tom with the education and confidence to join a startup in late 1989. Functioning as a member of ACT’s Office of the President, Tom oversaw all client-facing activities including sales, marketing, consulting, new product development, and strategic 3rd party relationships. ACT’s core leadership team built the company into one of the world’s largest and most-respected litigation automation firms.

Tom applied his experience and education to Tombot’s product development. Using a data-driven and human-centered design approach, Tom’s leadership has produced a product that we believe not only technically out-performs every competitive product on the market, but is also more highly-desired by our customers. Tom utilized his previous experience as an operator to institute the core financial, accounting, HR, sales and marketing systems to efficiently run and control Tombot’s key management disciplines.

A key feature of ACT was its organizational culture. Rooted in flat hierarchies and diverse, interdisciplinary teams and communications, ACT’s culture led to outlier stats for employee and client retention. Tom’s focus on organizational culture is the root source of Tombot’s success for taking diverse and independent high-performing team members and forming teams that generate results.

TERMS

TomBot
Overview
PRICE PER SHARE
$1.55
DEADLINE
Nov 3, 2021
VALUATION
$14.49M
AMOUNT RAISED
$555,931.91
Breakdown
MIN INVESTMENT
$249.55
MAX INVESTMENT
$499,999.00
MIN NUMBER OF SHARES OFFERED
6,450
OFFERING TYPE
Equity
ASSET TYPE
PREFERRED
SHARES OFFERED
Series Seed I Preferred
MAX NUMBER OF SHARES OFFERED
3,225,806

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

TomBot, Inc.

Corporate Address

:

19197 Golden Valley Road, #638, Santa Clarita, CA 91387

Offering Minimum

:

$9,999.05

Offering Maximum

:

$4,999,999.30

Minimum Investment Amount

(per investor)

:

$249.55











Terms


Offering Type

:

Equity

Security Name

:

Series Seed I Preferred

Minimum Number of Shares Offered

:

6,451

Maximum Number of Shares Offered

:

3,225,806

Price per Share

:

$1.55

Pre-Money Valuation

:

$14,491,624.25











Amount-Based:

$249 | Tier I

Priority Waitlist (after Kickstarter & Front of the Line Passes).

$1,000 | Tier II

Front of the Waitlist Line Pass.

$2,500 | Tier III

Front of the Waitlist Line Pass + Exclusive Annual Investor Call & Q&A.

$5,000 | Tier IV

Front of the Waitlist Line Pass + Exclusive Semi-Annual Major Annual Investor Call & Q&A.

$10,000 | Tier V

Front of the Waitlist Line + Exclusive Semi-Annual Major Investor Call & Q&A + Dinner and Private Tour of Tombot Robotics Lab + Invitations to Tombot Major Investor Events.

*All perks occur when the offering is completed.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative. Any expense labeled “Travel and Entertainment”.

PRESS

Article Image
BBC Click

The Robot Dog That Helps With Dementia

Article Image
CBS 8

Robotic Dog "Jenny" helping dementia patients

Article Image
Oprah Daily

Meet Jennie, a Robotic Dog That Provides Companionship To Those Who Are Unable to Care for a Pet.










ALL UPDATES

08.08.22

Tombot | Waitlist Confirmation Required

Hello Tombot Investor Family!

I am happy to report we are making progress towards bringing Jennie to market.  Over the past 12 months we have re-engineered all her mechanical and electrical subsystems. We now have complete mechanical assemblies, which will help us prepare for in-depth customer testing and ultimately manufacturing.  Additionally, customer demand remains very strong.  Our customer waitlist grows every day, seven days a week.  We even received a request for Jennie for use by astronauts!

Currently, we anticipate our first customer shipments in 2024. If you joined our waitlist prior to March 2022, you will receive an email requiring that you confirm that you wish to remain on our waitlist and that you intend to order a puppy.  The deadline to respond to the email is September 1st.  This updated information will allow us to size our first production orders and further forecast our business needs. When we get close to shipping, we will need payment of your order.   If you joined our waitlist in March 2022 or later, there is no need to confirm.

Important: Please use the email address you used to join our waitlist (the same email address at which you received the waitlist confirmation email).  If you joined our waitlist prior to March 2022 but did not receive an email from us, please check your spam / junk folder, as our emails sometimes get flagged as junk.  You need to click the link in the confirmation email in order to officially confirm. 

Thank you for your ongoing support!  Be on the look-out for more announcements in the coming weeks!

Be well,

Tom

11.06.21

Thank you for a strong finish!


Tombot Family, 👋


WOW! The outpouring of support we received in our equity crowdfunding campaign was inspiring!


Thanks to our 454 investors, we’ve raised $573k+ and expanded our TomBot family in the process! 


This brings us even closer to producing the first affordable, FDA-regulated robotic animal for people who cannot safely or practically care for live animals.


Be Well,

Tom Stevens

Founder & CEO

11.02.21

Last Roll Call❗It’s the FINAL Hours To Invest!


Tombot Family, 👋


Our campaign is officially coming to a close in less than 10 hours. Take advantage of the final hours of our equity crowdfunding campaign before it’s too late! 


Thanks to your support, Tombot is now the #1 Most-Funded Reg CF Health Tech campaign offering currently on StartEngine! With further investment from you - our valued community - we will continue climbing the ranks of StartEngine.


Tombot is making the first affordable, FDA-regulated robotic animals for people who cannot safely or practically care for live animals. We are so excited to share our progress with you!


Current investors are encouraged to reinvest. Potential investors, please visit our raise page on StartEngine. Join our growing global community of over 700 investors!


Be Well,

Tom Stevens

Founder & CEO

11.01.21

Only 1 Day Left to Invest in Tombot! ⏳ Join Our Final Webinar Today!

{Register here}


Tombot Family, 👋


There is only one day left to make an early-stage investment in Tombot! We are the third-most funded Regulation Crowdfunding Health Tech currently live campaign on StartEngine! This is your final chance to invest and help drive us to 1st place!


Your investment in an innovative medical robotics company like ours will help us make a difference in the lives of individuals across the globe suffering from cognitive health adversities such as dementia, autism, and PTSD.


Join the 400+ institutional and individual investors, including Wavemaker Three-Sixty Health, who have already backed Tombot. Visit our campaign page on StartEngine before time runs out.


PS: If you have any questions about the investment, this is your last chance to attend our exclusive investor Q&A webinar! Don’t miss this final opportunity to discuss our latest development work with Jennie, and Tombot in general. Register hereand join us Monday, November 1st, 2021 at 4:00PM PST! 


Be Well,

Tom Stevens

Founder & CEO

11.01.21

Fireside Chat With CC Degraff and Leandra Sims! 🎙


Tombot Family, 👋


I recently had the opportunity to sit down with CC DeGraff and Leandra Sims in a fireside chat about assisted living.


Fireside chats are interviews with experts from various fields of health, technology, and pets. 


CC is the Executive Director and Leandra is Director of Memory Care at the Kensington Assisted Living and Memory Care center in Sierra Madre.


On behalf of the entire Tombot team, I would like to thank these two dedicated professionals for sharing their insights.


Please read our recent investor article where I highlight some of the important topics we discussed!


For more information on how you can help us bring Tombot puppies to people desperately in need, please visit our website


Be Well,

Tom Stevens

Founder & CEO

Tombot

10.30.21

Invest Today: Only 3 Days Left! ⏳


Tombot family,


As our equity crowdfunding campaign comes to a close, there is still time for you to join the 350+ institutional and individual investors who have already backed Tombot.


Tombot is currently in third place for funds raised by Health Tech investments on StartEngine. We need your help to take us to number one!


There are only 3 days left to invest in Tombot. The minimum investment amount is $249.50.


Our mission is to improve quality of life for individuals suffering from health adversities. You can help us bring Puppies to those desperately in need.


If you have already invested, please consider reinvesting. Even modest contributions can make a difference.


Thank you to everyone who has already participated. Please spread the word and help us across the finish line!


Be Well,

Tom Stevens

Founder & CEO

10.30.21

Tombot’s Final Investor Q&A Webinar! 🎙


Tombot Family, 👋


This is your last chance to attend our exclusive investor Q&A webinar!


Don’t miss this final opportunity to discuss the latest equity crowdfunding campaign news, development work with Jennie, and Tombot in general.


Register here, and join us November 1st, 2021 at 4:00PM PST!


After you register, you’ll receive a confirmation email explaining how to join the webinar.


Don’t forget to bring your burning questions, as this will be the last event to get them answered live!


We look forward to seeing you there.


Be Well,

Tom Stevens

Founder & CEO

10.29.21

Early Bird Perks Are Almost Over! ⏰


Tombot family,


Reminder: these are the last few days to invest in Tombot. It’s your last chance to get early bird perks on StartEngine!


Anyone who joins our community as a new shareholder for the minimum investment of $249 will be put on the priority waitlist, which could save up to a year of waiting for Jennie the robot!


If you invest $1000, you will be rewarded with our Front of the Waitlist Line Pass, which will expedite your robot even sooner.


If you have any questions, or would like more information on the different tiers based on your investment amount, go to the rewards section of our raise page.


Please share this with your friends and network, and help us get Jennie to those who need her most.


Thank you for accelerating the growth of our mission.



Be Well,

Tom Stevens

Founder & CEO

10.29.21

Tombot Engineering Updates for October! 🐶


Tombot Family, 👋


I recently sat down in a fireside chat to discuss phase 1 of Jennie’s production, and am pleased to give you the Tombot engineering update for October, 2021.


We are currently in phase 1 of production engineering, which consists of high-level architectures all for the purposes of making her more robust.


Read our recent blog, in which we break down the four key elements of this phase of Jennie’s development.


I look forward to keeping you updated on future phases of development and milestones in our equity crowdfunding campaign.


We can’t thank you enough for your support.


Be Well,

Tom Stevens

Founder & CEO

10.28.21

Tombot’s Fireside Chat With Wavemaker Three-Sixty Health’s Jay Goss!

Tombot Family, 👋


We recently held a Fireside Chat with healthcare VC  Jay Goss.


Jay is a general partner at Wavemaker Three-Sixty Health - a Pasadena, California-based venture fund that focuses exclusively on healthcare startups seeking seed-stage investments. Jay also serves on Tombot's board of directors. 


On behalf of the entire Tombot team, I want to thank Jay for sharing his expertise. We learned so much about healthcare investment, and why it is “recession-resistant.”


If you missed this insightful discussion, we encourage you to watch our recap video on YouTube or check out our recent investor article.


Thank you for your continued support of our mission.


Be Well,

Tom Stevens

Founder & CEO










REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into TomBot.

$249.00

Tier I

Priority Waitlist (after Kickstarter & Front of the Line Passes).

$1,000.00

Tier II

Front of the Waitlist Line Pass.

$2,500.00

Tier III

Front of the Waitlist Line Pass + Exclusive Annual Investor Call & Q&A.

$5,000.00

Tier IV

Front of the Waitlist Line Pass + Exclusive Semi-Annual Major Annual Investor Call & Q&A.

$10,000.00

Tier V

Front of the Waitlist Line + Exclusive Semi-Annual Major Investor Call & Q&A + Dinner and Private Tour of Tombot Robotics Lab + Invitations to Tombot Major Investor Events.

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.